Senseonics Holdings Announces Data From Eversense Post Approval Study To Be Presented At 17th International Conference On Advanced Technologies And Treatments for Diabetes
Senseonics Holdings宣布Eversense批准后研究的数据将在第17届糖尿病先进技术和治疗国际会议上公布
Senseonics Holdings Announces Data From Eversense Post Approval Study To Be Presented At 17th International Conference On Advanced Technologies And Treatments for Diabetes
Senseonics Holdings宣布Eversense批准后研究的数据将在第17届糖尿病先进技术和治疗国际会议上公布
使用浏览器的分享功能,分享给你的好友吧